Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities
Net income (loss)	$ (113,435)	$ 3,931
Adjustments to reconcile net income (loss) to operating activities:
Amortization, depreciation and write-offs	445,507	315,409
Amortization of debt issuance costs and discount	9,685	8,980
Stock-based compensation	143,943	91,828
Change in operating right-of-use asset	13,725	18,199
Other	2,133	3,237
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(139,350)	(99,999)
Prepaid expenses and other current assets	(70,242)	(107,461)
Other assets	(4,616)	7,729
Accounts payable	(7,881)	49,345
Operating lease liabilities	(15,345)	(18,270)
Accrued and other liabilities	(2,645)	11,211
Deferred revenue	(11,905)	(7,303)
Net cash provided by operating activities	249,574	276,836
Investing Activities
Purchase of property and equipment	(621)	(962)
Acquisitions, net of cash acquired	(1,335,698)	(1,198,789)
Purchase of non-marketable investments and other	(56,546)	(15,000)
Proceeds from other investing activities	3,657	11,358
Capitalized software development costs	(4,546)	(2,859)
Net cash used in investing activities	(1,393,754)	(1,206,252)
Financing Activities
Proceeds from issuance of common stock in initial public offering, including cost reimbursement	0	1,745,228
Proceeds from debt issuance, net of issuance costs	0	844,729
Payments of debt principal	(17,482)	(711,482)
Payments of finance leases	(18,099)	(9,690)
Proceeds from exercise of stock options	21,733	25,486
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan	3,663	0
Payments of deferred acquisition costs	(104,998)	(231,664)
Payments of licensed asset obligation	(17,374)	0
Repurchases of stock	(338,880)	0
Net cash provided by (used in) financing activities	(471,437)	1,662,607
Effect of foreign exchange rate on cash and cash equivalents	(11,379)	(809)
Net increase (decrease) in cash and cash equivalents	(1,626,996)	732,382
Cash, cash equivalents and restricted cash equivalents at beginning of the period	2,570,504	317,235
Cash and cash equivalents at end of the period	943,508	1,049,617
Supplemental non-cash investing and financing activities disclosures:
Issuance of common stock in connection with an acquisition	137,422	0
Acquisitions not yet paid	40,791	74,347
Settlement of convertible security through issuance of common stock	0	25,000
Assets acquired under finance leases	37,433	12,584
Right of use assets acquired under operating leases	3,400	3,508
Settlement of bonus compensation through issuance of common stock	0	2,503
Issuance of convertible security related to acquisitions	0	342,170
Supplemental disclosure of cash flow information:
Cash paid for interest on debt	107,650	47,021
Cash paid for income taxes, net of refunds	$ 58,770	$ 72,182